rxstatShortages › Omeprazole

Omeprazole (Losec, Omep) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 28, 2026

Also sold as: Losec, Omep, Losec Mups, Heartburn Control

Some Omeprazole products are in shortage in Canada (10 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 25, 2026.

A proton pump inhibitor used to reduce stomach acid in conditions such as acid reflux and ulcers.

Products affected
10 / 22
In shortage since
Dec 14, 2018
Est. full return
Sep 25, 2026
Reports on file
88
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
JAMP-OMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02420198 · since Jan 19, 2024, est. end Sep 25, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-OMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02420198 · since Jan 19, 2024, est. end Sep 25, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-OMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02420198 · since Jan 19, 2024, est. end Sep 25, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-OMEPRAZOLE
20MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02245058 · since Jun 16, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-OMEPRAZOLE
10MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02295407 · since Aug 27, 2025, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-OMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02295415 · since Nov 7, 2024, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-OMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02295415 · since Dec 3, 2025, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-OMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · NATCO PHARMA (CANADA) INC
DIN 02439549 · since Jun 13, 2024, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
BIO-OMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · BIOMED PHARMA
DIN 02449927 · since Oct 17, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS
20MG · TABLET (DELAYED-RELEASE) · SANIS HEALTH INC
DIN 02504294 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS
20MG · TABLET (DELAYED-RELEASE) · ACCORD HEALTHCARE INC
DIN 02416549 · since Apr 12, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
PMS-OMEPRAZOLE
20MG · CAPSULE (DELAYED RELEASE) · PHARMASCIENCE INC
DIN 02320851 · since Feb 28, 2019, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Omeprazole is currently affected by 10 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, APOTEX INC, TEVA CANADA LIMITED, NATCO PHARMA (CANADA) INC and 5 others.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; the product will be discontinued as of november 16, 2019. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Omeprazole is classified under “DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)” (ATC A02BC).

Recent changes

Common questions

What is Omeprazole used for?

A proton pump inhibitor used to reduce stomach acid in conditions such as acid reflux and ulcers.

When will Omeprazole be back in stock in Canada?

The latest manufacturer estimate is Sep 25, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Omeprazole in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (drugs for peptic ulcer and gastroesophageal reflux disease (gerd))

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.